Sentences with phrase «stage vaccine company»

Novavax, Inc. (NASDAQ: NVAX), a small - cap clinical - stage vaccine company that focuses on therapies for both known and newly emerging diseases, has lost some support from a Wall Street analyst.

Analysts at Citi turned bullish on Novavax, Inc. (NASDAQ: NVAX), a small - cap clinical - stage vaccine company.

Not exact matches

Although the company's efforts in this area are still in the early - stage phase, an effective flu vaccine could be worth up to $ 3 billion per year in sales, according to Research and Markets.

Several research institutions and companies have vaccine and drug candidates nearly ready to test, but until now a mouse model — a critical stage in preclinical testing — has not been available.

Activists often slam large pharmaceutical companies for failing to develop drugs that are of critical importance to the developing world.Andrew Witty, GlaxoSmithKline's youthful chief executive, gave those critics pause yesterday in a speech to the Council on Foreign Relations in New York City.Witty promised to sell the company's malaria vaccine that is in late - stage clinical trials in Africa for no more than a 5 percent profit.

Pigs will be tested at different developmental stages using adjuvants that are commercially available and / or undergoing evaluation, from human and veterinary vaccine companies.

CAMBRIDGE, Mass., April 27, 2017 — Moderna Therapeutics, a clinical stage biotechnology company that is pioneering messenger RNA (mRNA) Therapeutics ™ to create a new generation of transformative medicines for patients, today announced positive interim data from an ongoing Phase 1 study of mRNA - 1440, an mRNA infectious disease vaccine against avian H10N8 influenza, demonstrating mRNA - 1440 induced high levels of immunogenicity, and was safe and well tolerated.

Immediately prior to joining Hookipa, he was a Member of the Management Board and CFO of Valneva SE, a commercial stage biotech vaccine company, listed on the Euronext Paris and the Vienna Stock Exchange.

CAMBRIDGE, Mass., July 13, 2017 — Moderna Therapeutics, a clinical stage biotechnology company that is pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced new data demonstrating that its Zika mRNA vaccine prevented Zika virus transmission from pregnant mice to their fetuses.

In 2005, Dan co-founded and served as President and CEO of Inviragen Inc., which he transformed from a virtual start - up to a global clinical stage company with sites in Colorado, Wisconsin and Singapore and translated two vaccines from the research bench to human clinical trials, including one for dengue fever.

Each company has contributed product candidates to the collaboration: Sanofi Pasteur will contribute HSV - 529, a clinical - stage replication - defective HSV vaccine product candidate, and Immune Design will contribute G103, its preclinical trivalent vaccine product candidate.

About 15 companies are working on Zika vaccines, most in the initial stages, according to the World Health Organization.